journal article·2019-11-05Open access

A Review of Neurotransmitters Sensing Methods for Neuro-Engineering Research

Shimwe Dominique Niyonambaza, Praveen Kumar, Paul Xing, Jessy Mathault, Paul De Koninck, Elodie Boisselier, Mounir Boukadoum, Amine Miled

Applied Sciences· Volume 9· Issue 21

Abstract

Neurotransmitters as electrochemical signaling molecules are essential for proper brain function and their dysfunction is involved in several mental disorders. Therefore, the accurate detection and monitoring of these substances are crucial in brain studies. Neurotransmitters are present in the nervous system at very low concentrations, and they mixed with many other biochemical molecules and minerals, thus making their selective detection and measurement difficult. Although numerous techniques to do so have been proposed in the literature, neurotransmitter monitoring in the brain is still a challenge and the subject of ongoing research. This article reviews the current advances and trends in neurotransmitters detection techniques, including in vivo sampling and imaging techniques, electrochemical and nano-object sensing techniques for in vitro and in vivo detection, as well as spectrometric, analytical and derivatization-based methods mainly used for in vitro research. The document analyzes the strengths and weaknesses of each method, with the aim to offer selection guidelines for neuro-engineering research.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neuroscience and Neuropharmacology Research · Molecular Sensors and Ion Detection · Electrochemical sensors and biosensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

LABioTRON Bioeng. Research Laboratory, ECE Dept. Université Laval, Québec City, QC G1V 0A6, Canada

CUO-Recherche, Hôpital du Saint-Sacrement, Québec City, QC G3K 1A3, Canada

Neurosciences Dept. University of Montreal, Montreal, QC H3C 3J7, Canada

CERVO Brain Research Center, Québec City, QC G1J 2G3, Canada

Ophthalmology Department, Faculty of Medicine, Université Laval, Québec City, QC G1V 0A6, Canada

CoFaMic, Université du Québec à Montréal, Montreal, QC H2L 2C4, Canada

References (100+)

Show source-provided references
1. Analytical and Quantitative in Vivo Monitoring of Brain Neurochemistry by Electrochemical and Imaging Approaches10.1021/acsomega.8b02055 ↗
2. Direct targeted quantitative molecular imaging of neurotransmitters in brain tissue sections10.1016/j.neuron.2014.10.011 ↗
3. MALDI imaging mass spectrometry: Molecular snapshots of biochemical systems10.1038/nmeth1094 ↗
4. Dual-Mode Optical Sensing of Histamine at Nanomolar Concentrations in Complex Biological Fluids and Living Cells10.1002/chem.201702208 ↗
5. Application of cross-species PET imaging to assess neurotransmitter release in brain10.1007/s00213-015-3938-6 ↗
6. Combined PET/MRI: From status quo to status go. summary report of the fifth international workshop on PET/MR imaging; February 15–19, 2016; Tübingen, Germany10.1007/s11307-016-0993-2 ↗
7. Nanomaterial-based electrochemical sensing of neurological drugs and neurotransmitters10.1007/s00604-014-1308-4 ↗
8. Identification of catecholamine neurotransmitters using fluorescence sensor array10.1016/j.aca.2016.02.037 ↗
9. Microelectronics-based biosensors dedicated to the detection of neurotransmitters: A review10.3390/s141017981 ↗
10. Advanced materials for optical sensing and biosensing of neurotransmitters10.1016/j.trac.2015.03.017 ↗
11. Recent developments in electrochemical sensors for the detection of neurotransmitters for applications in biomedicine10.1080/00032719.2014.976867 ↗
12. Analysis of amino acid neurotransmitters from rat and mouse spinal cords by liquid chromatography with fluorescence detection10.1016/j.jpba.2014.12.024 ↗
13. Thal, L.B., Bailey, D.M., Kovtun, O., and Rosenthal, S.J. (2017). Quantum dot toolbox in membrane neurotransmitter transporter research. Chemical and Synthetic Approaches in Membrane Biology, Springer.10.1007/8623_2016_12 ↗
14. Biosensors for Detection of Neurotransmitters and Neurodegenerative Related Diseases10.2174/9781681085852117050007 ↗
15. Kandel, E.R., Schwartz, J.H., Jessell, T.M., Siegelbaum, S.A., and Hudspeth, A.J. (2000). Principles of Neural Science, McGraw-hill.
16. The Endocrine Brain: Pathophysiological Role of Neuropeptide-Neurotransmitter Interactions
17. Sapolsky, R. (2006). Biology and Human Behavior: The Neurological Origins of Individuality, Great Courses.
18. Shepherd, G.M. (2003). The Synaptic Organization of the Brain, Oxford University Press.10.1093/acprof:oso/9780195159561.001.1 ↗
19. Sanes, D.H., Reh, T.A., and Harris, W.A. (2011). Development of the Nervous System, Academic Press.
20. LTP and LTD: An embarrassment of riches10.1016/j.neuron.2004.09.012 ↗
21. Tripartite synapses: Glia, the unacknowledged partner10.1016/S0166-2236(98)01349-6 ↗
22. New insights into neuron-glia communication10.1126/science.298.5593.556 ↗
23. Glutamate, GABA and epilepsy10.1016/0301-0082(95)00030-5 ↗
24. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-110.1126/science.276.5319.1699 ↗
25. Glutamate and epilepsy10.1093/jn/130.4.1043S ↗
26. Bringing order to the glutamate chaos in schizophrenia10.1016/S0896-6273(03)00757-8 ↗
27. Aspartate release and signalling in the hippocampus10.1007/s11064-010-0291-3 ↗
28. l-Aspartate as an amino acid neurotransmitter: Mechanisms of the depolarization-induced release from cerebrocortical synaptosomes10.1111/j.1471-4159.2009.06187.x ↗
29. Aspartate and glutamate as possible neurotransmitters in the visual cortex10.1523/JNEUROSCI.01-04-00427.1981 ↗
30. Aspartate and glutamate as possible neurotransmitters of cells in layer 6 of the visual cortex10.1038/287848a0 ↗
31. Pharmacological evidence for L-aspartate as the neurotransmitter of cerebellar climbing fibres in the guinea-pig10.1113/jphysiol.1985.sp015761 ↗
32. Aspartate: Possible neurotransmitter in cerebellar climbing fibers10.1126/science.6121375 ↗
33. Aspartate release from rat hippocampal synaptosomes10.1016/j.neuroscience.2004.06.065 ↗
34. In vivo release of endogenous amino acids from the rat striatum: Further evidence for a role of glutamate and aspartate in corticostriatal neurotransmission10.1111/j.1471-4159.1986.tb02836.x ↗
35. Evidence for neuronal origin and metabotropic receptor-mediated regulation of extracellular glutamate and aspartate in rat striatum in vivo following electrical stimulation of the prefrontal cortex10.1046/j.1471-4159.1998.70020617.x ↗
36. Excitatory amino acid neurotransmitters in the corticostriate pathway: Studies using intracerebral microdialysis in vivo10.1111/j.1471-4159.1986.tb00771.x ↗
37. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release
38. Excitatory actions of gaba during development: The nature of the nurture10.1038/nrn920 ↗
39. Excitatory GABA action is essential for morphological maturation of cortical neurons in vivo10.1523/JNEUROSCI.5169-06.2007 ↗
40. GABA and glycine as neurotransmitters: A brief history10.1038/sj.bjp.0706443 ↗
41. Glycine as a neurotransmitter in the forebrain: A short review10.1007/s00702-009-0326-6 ↗
42. Glycine—An important neurotransmitter and cytoprotective agent10.1111/j.1399-6576.2005.00786.x ↗
43. Glycine-dependent activation of NMDA receptors10.1085/jgp.201411302 ↗
44. Glycine receptors: Recent insights into their structural organization and functional diversity10.1111/j.1471-4159.2006.03908.x ↗
45. D-Serine as a putative glial neurotransmitter10.1017/S1740925X05000141 ↗
46. D-amino acids as putative neurotransmitters: Focus on D-serine10.1023/A:1007586314648 ↗
47. D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration10.1111/j.1742-4658.2008.06515.x ↗
48. D-Serine as a glial modulator of nerve cells10.1002/glia.20073 ↗
49. D-serine, an endogenous synaptic modulator: Localization to astrocytes and glutamate-stimulated release10.1073/pnas.92.9.3948 ↗
50. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia10.1016/j.biopsych.2004.12.037 ↗
51. High dose D-serine in the treatment of schizophrenia10.1016/j.schres.2010.05.012 ↗
52. Dopamine neuron systems in the brain: An update10.1016/j.tins.2007.03.006 ↗
53. Dopamine, learning and motivation10.1038/nrn1406 ↗
54. The role of dopamine for the pathophysiology of schizophrenia10.1080/09540260701502468 ↗
55. The dopamine hypothesis of schizophrenia: Version III—the final common pathway10.1093/schbul/sbp006 ↗
56. Norepinephrine: Hormone and neurotransmitter in man10.1152/ajpendo.1978.234.3.E252 ↗
57. Purves, D., Augustine, G.J., Fitzpatrick, D., Hall, W., LaMantia, A., McNamara, J., and White, L. (2004). Neuroscience Third Edition, Sinauer Associates.
58. The importance of norepinephrine in depression
59. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: Basic studies10.1016/S0014-2999(00)00569-0 ↗
60. Rhoadesand, R., and Bell, D. (2009). Medical Physiology: Principles for Clinical Medicine, Lippincott Williams & Wilkins.
61. Khurana, I. (2008). Essentials of Medical Physiology, Elsevier.
62. The spectrum of behaviors influenced by serotonin10.1016/S0006-3223(98)00139-5 ↗
63. Role of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive review10.1016/S0278-5846(02)00338-X ↗
64. Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects10.1016/S0165-0327(98)00221-3 ↗
65. Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia10.1007/BF00442554 ↗
66. The role of histamine and the tuberomamillary nucleus in the nervous system10.1038/nrn1034 ↗
67. Histamine function in brain disorders10.1016/S0166-4328(01)00215-7 ↗
68. The role of central histaminergic neuron system as an anticonvulsive mechanism in developing brain10.1016/S0387-7604(01)00261-3 ↗
69. Henry Dale and the discovery of acetylcholine10.1016/j.crvi.2006.03.012 ↗
70. Acetylcholine in mind: A neurotransmitter correlate of consciousness?10.1016/S0166-2236(98)01361-7 ↗
71. Dementia with Lewy bodies10.1016/j.ncl.2007.03.001 ↗
72. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats10.1016/0006-8993(94)01399-3 ↗
73. Historical review: ATP as a neurotransmitter10.1016/j.tips.2006.01.005 ↗
74. Signaling by gasotransmitters10.1126/scisignal.268re2 ↗
75. Carbon monoxide excitatory effect in vasopressin neurons of heart failure rats involves nitric oxide/GABA signaling (686.24)10.1096/fasebj.28.1_supplement.686.24 ↗
76. Nitric oxide and hydrogen sulfide: The gasotransmitter paradigm of the vascular system10.1111/bph.13815 ↗
77. Hydrogen sulfide: The third gasotransmitter in biology and medicine10.1089/ars.2009.2938 ↗
78. In vivomonitoring of amine neurotransmitters using microdialysis with on-line capillary electrophoresis10.1002/1522-2683(200109)22:17<3668::AID-ELPS3668>3.0.CO;2-M ↗
79. 4-Fluoro-7-nitro-2, 1, 3-benzoxadiazole as a fluorogenic labeling reagent for the in vivo analysis of amino acid neurotransmitters using online microdialysis- capillary electrophoresis10.1021/ac071433o ↗
80. Monitoring dopamine in vivo by microdialysis sampling and on-line CE-laser-induced fluorescence10.1021/ac0608218 ↗
81. Discovery of dopamine glucuronide in rat and mouse brain microdialysis samples using liquid chromatography tandem mass spectrometry10.1021/ac801846w ↗
82. Determination of isatin and monoamine neurotransmitters in rat brain with liquid chromatography using palladium hexacyanoferrate modified electrode10.1016/j.aca.2006.06.042 ↗
83. Critical evaluation of acetylcholine determination in rat brain microdialysates using ion-pair liquid chromatography with amperometric detection10.3390/s8085171 ↗
84. A highly sensitive and stable detection of acetylcholine by HPLC-osmium-horseradish peroxidase redox polymer electrode coated on a gold radial flow ring disk10.1016/j.aca.2004.06.062 ↗
85. A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid10.1016/S0196-9781(00)00219-9 ↗
86. Tatemoto, K. (2004). Neuropeptide Y: History and overview. Neuropeptide Y and Related Peptides, Springer.10.1007/978-3-642-18764-3_1 ↗
87. Neuropeptide Y and epilepsy10.1111/j.1535-7597.2003.03208.x ↗
88. Microelectrode biosensor for real-time measurement of ATP in biological tissue10.1021/ac048106q ↗
89. A cytochrome c modified-conducting polymer microelectrode for monitoring in vivo changes in nitric oxide10.1016/j.bios.2007.12.008 ↗
90. Hydrogen sulfide is produced in response to neuronal excitation10.1523/JNEUROSCI.22-09-03386.2002 ↗
91. Gazzaniga, M., Ivry, R., and Mangun, G. (1998). Cognitive Neuroscience: The Biology of the Mind, WW Norton & Co.
92. Huettel, S.A., Song, A.W., and McCarthy, G. (2004). Functional Magnetic Resonance Imaging, Sinauer Associates.
93. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum10.1016/S0893-133X(99)00079-2 ↗
94. Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels10.1002/syn.890130407 ↗
95. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—A PET study with [11C] raclopride10.1016/S0893-133X(98)00108-0 ↗
96. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis10.1523/JNEUROSCI.15-01-00821.1995 ↗
97. SPECT imaging of striatal dopamine release after amphetamine challenge
98. Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates10.1002/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H ↗
99. Single-photon emission computed tomography10.1109/PROC.1983.12590 ↗
100. Single-molecule surface-enhanced Raman spectroscopy of nonresonant molecules10.1021/ja905319w ↗